DVHGF (Devonian Health Group) Interest Expense : $-0.23 Mil (TTM As of Oct. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Devonian Health Group Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Devonian Health Group's interest expense for the three months ended in Oct. 2024 was $ -0.07 Mil. Its interest expense for the trailing twelve months (TTM) ended in Oct. 2024 was $-0.23 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Devonian Health Group's Operating Income for the three months ended in Oct. 2024 was $ -0.24 Mil. Devonian Health Group's Interest Expense for the three months ended in Oct. 2024 was $ -0.07 Mil. Devonian Health Group did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Devonian Health Group Interest Expense Historical Data

The historical data trend for Devonian Health Group's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devonian Health Group Interest Expense Chart

Devonian Health Group Annual Data

Trend

Jun15

Jun16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

Interest Expense

Get a 7-Day Free Trial

-0.57

-0.63

-0.72

-0.35

-0.28

Devonian Health Group Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Interest Expense	Get a 7-Day Free Trial															-0.09	-0.05	-0.07	-0.05	-0.07

Devonian Health Group Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.23 Mil.

Devonian Health Group (OTCPK:DVHGF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Devonian Health Group's Interest Expense for the three months ended in Oct. 2024 was $-0.07 Mil. Its Operating Income for the three months ended in Oct. 2024 was $-0.24 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Oct. 2024 was $0.08 Mil.

Devonian Health Group's Interest Coverage for the quarter that ended in Oct. 2024 is calculated as

Devonian Health Group did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Devonian Health Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (OTCPK:DVHGF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

GSD:Canada

Address

360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1

Website

https://www.groupedevonian.com

Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines

From GuruFocus

Devonian Announces the Closing of a $315,000 Private Placement and an Additional Loan of $500,000

By GlobeNewswire GlobeNewswire • 08-22-2019